Levels of corticosteroid-binding globulin mRNA in human ovarian cancers

Tumor Biology

Volumn 20, Issue 5, 1999, Pages 263-269

  Misao, Ryou ^a   Iwagaki, Shigenori ^a   Sun, Wen Shu ^a   Fujimoto, Jiro ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Corticosteroid binding globulin; mRNA; Ovarian cancer

Indexed keywords

ESTROGEN; MESSENGER RNA; PROGESTERONE; TRANSCORTIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; OVARY CANCER; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0032783104     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030073     Document Type: Article

References (29)

1. Rao MC, Midgley AR, Richards JS: Hormonal regulation of ovarian cellular proliferation. Cell 1978;14:71-74.
2. Goodman AL, Hodgen GD: Systemic versus intraovarian progesterone replacement after luteectomy in rhesus monkeys: Differential patterns of gonadotropins and follicule growth. J Clin Endocrinol Metab 1977;45:837-844.
3. Louvet JP, Harman SM, Schreiber JR, Ross GT: Evidence for a role of androgens in follicular maturation. Endocrinology 1975;97:366-372.
4. Jänne O, Kauppila A, Syrjäla P, Vihko R: Comparison of cytosol estrogen and progestin receptor status in malignant and benign tumors and tumor-like lesions of human ovary. Int J Cancer 1980;25:175-179.
5. Hamilton TC, Davies P, Griffiths K: Androgen and oestrogen binding in cytosols of human ovarian tumors. J Endocrinol 1981;90:421-431.
6. Kusanishi H, Tamaya T, Yamada T, Wada K, Fujimoto J, Ohno Y, Okada H: Characterization of steroid receptors in human ovarian cancer. Asia-Oceania J Obstet Gynaecol 1982;8:427-432.
7. Slotman BJ, Kühnel R, Rao BR, Dijkhuizen GH, Graaff J, Stolk JG: Importance of steroid receptors and aromatase activity in the prognosis of ovarian cancer: High tumor progesterone receptor levels correlate with longer survival. Gynecol Oncol 1989;33:76-81.
8. Milwidsky A, Younes MA, Besch NF, Besch PK, Kaufman RH: Receptor-like binding proteins for testosterone and progesterone in the human ovary. Am J Obstet Gynecol 1980;138:93-98.
9. Belinson JL, Mcclure M, Badger G: Randomized trial of megestrol acetate vs. megestrol acetate/tamoxifen for the management of progressive or recurrent epithelial ovarian carcinoma. Gynecol Oncol 1987;28:151-155.
10. Weiner SA, Alberts DS, Surwit EA, Davis J, Grosso D: Tamoxifen therapy in recurrent epithelial ovarian cancer. Gynecol Oncol 1987;27: 208-213.
11. Hatch KD, Beecham JB, Blessing JA, Creasman WT: Responsiveness of patients with advanced ovarian carcinoma to tamoxifen: A gynecologic oncology group study of second-line therapy in 105 patients. Cancer 1991;68:269-271.
12. Fromm GL, Freedman RS, Fritsche HA, Atkinson EN, Scott W: Sequentially administered ethinyl estradiol and medroxyprogesterone acetate in the treatment of refractory epithelial ovarian carcinoma in patients with positive estrogen receptors. Cancer 1991;68:1885-1889.
13. Mercier-Bodard C, Alfsen A, Baulieu EE: Sex steroid binding plasma protein. Acta Endocrinol Suppl 1970;147:204-224.
14. Hryb DJ, Khan MS, Romas NA, Rosner W: Specific binding of human corticosteroid-binding globulin to cell membranes. Proc Natl Acad Sci USA 1986;83:3253-3256.
15. Avvakumov GV, Krupenko SA, Dubovskaya LV, Strel'chyonok OA: Interaction of the transcortin-progesterone complex with plasma membranes of human decidual endometrium cells. Biokhimiia 1988;53: 586-590.
16. Avvakumov GV, Strel'chyonok OA: Evidence for the involvement of the transcortin carbohydrate moiety in the glycoprotein interaction with the plasma membrane of human placental syncytiotrophoblast. Biochim Biophys Acta 1988;938:1-6.
17. Strel'chyonok OA, Avvakumov GV: Specific steroid-binding glycoproteins of human blood plasma: Novel data on their structure and function. J Steroid Biochem 1990;35:519-534.
18. Misao R, Hori M, Ichigo S, Fujimoto J, Tamaya T: Corticosteroid-binding globulin mRNA levels in human uterine endometrium. Steroids 1994;59:603-607.
19. Misao R, Nakanishi Y, Fujimoto J, Ichigo S, Hori M, Tamaya T: Corticosteroid-binding globulin mRNA levels in human uterine endometrial cancers. Steroids 1995;60:720-724.
20. Misao R, Fujimoto J, Ichigo S, Hori M, Nakanishi Y, Tamaya T: Expression of sex hormone-binding globulin mRNA in uterine cervical cancers. Tumor Biol 1997;18:6-12.
21. Hammond GL, Smith CL, Goping IS, Underhill DA, Harley MJ, Reventos J, Musto NA, Gunsalus GL, Bardin CW: Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors. Proc Natl Acad Sci USA 1987;84:5153-5157.
22. Vanden Heuvel JP, Tyson FL, Bell DA: Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. Biotechniques 1993;14:395-398.
23. Chomczynski P, Sacch N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
24. Perrot-Applanat M, Racadot O, Milgrom E: Specific localization of plasma corticosteroid-binding globulin immunoreactivity in pituitary corticotrophs. Endocrinology 1984; 115:559-569.
25. Al-Khouri H, Greenstein B: Role of corticosteroid-binding globulin in interaction of corticosterone with uterine and brain progesterone receptors. Nature 1980;287:58-60.
26. Kuhn R, Green A, Raymoure W, Siiteri P: Immunocytochemical localization of corticosteroid-binding globulin in rat tissues. J Endocrinol 1986;108:31-36.
27. Misao R, Nakanishi Y, Fujimoto J, Tamaya T: Effect of sex steroid hormones on corticosteroid-binding globulin mRNA in human endometrial cancer cells. Ann Clin Biochem 1998;35:637-642.
28. Pascal RR, Grecco LA: Mucinous cystadenoma of the ovary with stromal luteinization and hilar cell hyperplasia during pregnancy. Hum Pathol 1988;19:179-180.
29. Oliva E, Andrada E, Pezzica E, Prat J: Ovarian carcinomas with choriocarcinomatous differentiation. Cancer 1993;72:2441-2446.